Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study
A. Khemis, Éric Fontas, Sophie Moulin, Henri Montaudié, J.‐P. Lacour, Thierry Passeron
Topics & Concepts
VitiligoMedicineApremilastRandomized controlled trialPlaceboDermatologyInternal medicinePsoriasisAlternative medicinePsoriatic arthritisPathologymelanin and skin pigmentationMast cells and histamineDermatologic Treatments and Research